These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update. Ascherio A; Munger KL Semin Neurol; 2016 Apr; 36(2):103-14. PubMed ID: 27116717 [TBL] [Abstract][Full Text] [Related]
24. Environmental factors in multiple sclerosis. Pantazou V; Schluep M; Du Pasquier R Presse Med; 2015 Apr; 44(4 Pt 2):e113-20. PubMed ID: 25744944 [TBL] [Abstract][Full Text] [Related]
25. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk. Strautins K; Tschochner M; James I; Choo L; Dunn DS; Pedrini M; Kermode A; Carroll W; Nolan D Mult Scler; 2014 Mar; 20(3):286-94. PubMed ID: 23886832 [TBL] [Abstract][Full Text] [Related]
26. Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis. Jelinek GA; Marck CH; Weiland TJ; Pereira N; van der Meer DM; Hadgkiss EJ BMC Neurol; 2015 Aug; 15():132. PubMed ID: 26243188 [TBL] [Abstract][Full Text] [Related]
28. Multiple sclerosis: risk factors and their interactions. Disanto G; Morahan JM; Ramagopalan SV CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):545-55. PubMed ID: 22583442 [TBL] [Abstract][Full Text] [Related]
29. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ascherio A; Munger KL Ann Neurol; 2007 Jun; 61(6):504-13. PubMed ID: 17492755 [TBL] [Abstract][Full Text] [Related]
30. Western lifestyle and immunopathology of multiple sclerosis. Matveeva O; Bogie JFJ; Hendriks JJA; Linker RA; Haghikia A; Kleinewietfeld M Ann N Y Acad Sci; 2018 Apr; 1417(1):71-86. PubMed ID: 29377214 [TBL] [Abstract][Full Text] [Related]
32. Sociodemographic, environmental and lifestyle risk factors for multiple sclerosis development in the Western region of Saudi Arabia. A matched case control study. Halawani AT; Zeidan ZA; Kareem AM; Alharthi AA; Almalki HA Saudi Med J; 2018 Aug; 39(8):808-814. PubMed ID: 30106419 [TBL] [Abstract][Full Text] [Related]
33. The causal cascade to multiple sclerosis: a model for MS pathogenesis. Goodin DS PLoS One; 2009; 4(2):e4565. PubMed ID: 19242548 [TBL] [Abstract][Full Text] [Related]
35. Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis. Taylor KL; Hadgkiss EJ; Jelinek GA; Weiland TJ; Pereira NG; Marck CH; van der Meer DM BMC Psychiatry; 2014 Dec; 14():327. PubMed ID: 25467385 [TBL] [Abstract][Full Text] [Related]
37. Epidemiology of multiple sclerosis: from risk factors to prevention. Ascherio A; Munger K Semin Neurol; 2008 Feb; 28(1):17-28. PubMed ID: 18256984 [TBL] [Abstract][Full Text] [Related]
38. On the Nature of Evidence and 'Proving' Causality: Smoking and Lung Cancer vs. Sun Exposure, Vitamin D and Multiple Sclerosis. Lucas RM; Rodney Harris RM Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30103527 [TBL] [Abstract][Full Text] [Related]
39. Vitamin D: a candidate for the environmental effect in multiple sclerosis - observations from Norway. Kampman MT; Brustad M Neuroepidemiology; 2008; 30(3):140-6. PubMed ID: 18382112 [TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies. Fernández-Menéndez S; Fernández-Morán M; Fernández-Vega I; Pérez-Álvarez A; Villafani-Echazú J J Neurol Sci; 2016 Feb; 361():213-9. PubMed ID: 26810546 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]